Evaluation of Repeat Administration of Purified Poloxamer 188 (EPIC-E)

The purpose of this study is to evaluate the safety of repeat administration of MST-188 during vaso-occlusive crisis of sickle cell disease. Additionally, this study will evaluate the development of acute chest syndrome during VOC and re-hospitalization for recurrence of VOC.

See detailed information including eligibility.

06/2015
NCT02449616
Sickle Cell
Accepting Participants